ZURVITA HOLDINGS INC

$ 0

Last Updated 26.08.2025

Issuer Rating

Performance

Favourable

Risk

Negligible

Recommendation

Sell

Market Cap

$ 13032

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

$ 0

Key Takeaways

Risk factor

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Zurvita Holdings, Inc. markets health and wellness products in the United States, Hong Kong, Canada, Singapore, Australia, the United Kingdom, and the Dominican Republic. Its principal products comprise Zeal Wellness, an antioxidants and vitamins nutritional product in wild berry and bold grape flavors; Zeal Advanced Formula Protein Shakes, a source of dietary fiber in chocolate...

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks